Tandem Diabetes Care Inc (TNDM)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-96,025	-126,782	-136,492	-141,453	-222,611	-208,461	-224,470	-203,751	-94,593	-67,933	-13,169	5,895	15,566	21,758	6,556	-24,559	-34,382	-48,730	-42,223	-16,628
Total assets	US$ in thousands	967,658	957,730	937,503	941,045	952,658	939,909	946,676	954,145	1,052,780	1,047,520	1,036,580	1,015,280	905,137	850,279	795,250	754,273	716,415	672,988	616,239	343,327
ROA		-9.92%	-13.24%	-14.56%	-15.03%	-23.37%	-22.18%	-23.71%	-21.35%	-8.99%	-6.49%	-1.27%	0.58%	1.72%	2.56%	0.82%	-3.26%	-4.80%	-7.24%	-6.85%	-4.84%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-96,025K ÷ $967,658K
= -9.92%

Tandem Diabetes Care Inc's return on assets (ROA) has fluctuated significantly over the reporting periods from March 31, 2020, to December 31, 2024. The company started with negative ROA figures ranging from -4.84% to -7.24% in 2020 and early 2021, indicating inefficiency in generating profits relative to its total assets.

From June 30, 2021, there was a positive shift in ROA, reaching a peak of 2.56% by September 30, 2021. This improvement indicated Tandem Diabetes Care Inc's ability to generate higher profits relative to its assets, possibly due to enhanced operational efficiency or better asset utilization.

However, the positive trend was short-lived as the ROA declined in the following quarters, dropping to negative figures again by March 31, 2023. The ROA continued to deteriorate over the next reporting periods, reaching the lowest point of -23.71% by June 30, 2023, indicating a significant decline in profitability relative to its assets.

Although there was a slight recovery in the ROA by December 31, 2024, the ratio remained negative, ranging from -9.92% to -13.24%. This suggests that Tandem Diabetes Care Inc faced challenges in efficiently utilizing its assets to generate profits during the later reporting periods.

Overall, the analysis shows a mixed performance in terms of ROA for Tandem Diabetes Care Inc, with periods of both improvement and decline. Further investigation into the company's operations and financial strategies may be needed to understand the factors contributing to these fluctuating ROA figures.